N
MACK

Natixis’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Natixis’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-20,443
Closed -$234K – 1376
2017
Q3 		$234K Buy
+20,443
New +$234K ﹤0.01% 1040